Search Results - K.G. van der Hem
- Showing 1 - 2 results of 2
-
1
Quality of life of patients with chronic lymphocytic leukaemia in the Netherlands: results of a longitudinal multicentre study by Kim Holtzer-Goor, Martyn Ronald Schaafsma, Peter Joosten, E.F.M. Posthuma, S. Wittebol, Peter C. Huijgens, E. J. M. Mattijssen, Gerard Vreugdenhil, Hein P. J. Visser, W Peters, Z. Erjavec, P. Wijermans, Simon Daenen, K.G. van der Hem, Marinus H. J. van Oers, Carin A. Uyl‐de Groot
Published 2015Artigo -
2
Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma by Sonja Zweegman, Bronno van der Holt, Ulf‐Henrik Mellqvist, Morten Salomo, Gerard M.J. Bos, Mark‐David Levin, Heleen Visser-Wisselaar, Markus Hansson, Annette W.G. van der Velden, Wendy Deenik, Astrid Gruber, J.L. Coenen, Torben Plesner, Saskia K. Klein, Bea C. Tanis, Damian Szatkowski, Rolf E. Brouwer, Matthijs Westerman, Mark Leys, Harm Sinnige, Einar Haukås, K.G. van der Hem, Marc Durian, E. J. M. Mattijssen, Niels W.C.J. van de Donk, Marian Stevens‐Kroef, Pieter Sonneveld, Anders Waage
Published 2016Artigo
Search Tools:
Related Subjects
Chemotherapy
Internal medicine
Medicine
Apathy
Chlorambucil
Confidence interval
Cyclophosphamide
Disease
Environmental health
Gastroenterology
Hazard ratio
Lenalidomide
Maintenance therapy
Melphalan
Multiple myeloma
Neutropenia
Nursing
Observational study
Oncology
Pediatrics
Physical therapy
Population
Prednisone
Quality of life (healthcare)
Regimen
Surgery
Thalidomide